Inflammatory Breast Cancer International Consortium | IBC-IC HomepageInflammatory Breast Cancer International Consortium | IBC-IC

Filipa Lynce, MD

Clinician + Researcher

Title(s)

  • Assistant Professor, Medicine, Harvard Medical School
  • Physician, Medical Oncology, Dana-Farber Cancer Institute
  • Associate Physician, Medical Oncology, Brigham and Women’s Hospital

Location(s)

  • Dana-Farber Cancer Institute
  • 450 Brookline Avenue
  • Yawkey 1275
  • Brookline, MA, 02215
  • United States of America
  • Phone: 617.632.3800

Research and Clinical Interests

IBC-Focused Research

My specific area of clinical expertise is the treatment of patients with IBC, triple negative breast cancer, and BRCA associated cancers. While I was at MedStar Georgetown University Hospital (MGUH), my referral base was mainly community doctors and doctors in academia who sent me patients specifically for the trials I developed, and I have started a similar pattern of referrals at DFCI. My current clinical activities include attending on the Medical Oncology inpatient service at BWH two to four weeks per year, and seeing patients in the ambulatory clinic at DFCI four half-day sessions per week. I am often asked to give talks to trainees about these topics and to speak at different meetings on various aspects of breast cancer treatment and research. I conducted the first study to evaluate the uptake of prophylactic BSO in Latinas with BRCA1/2 mutations and we showed for the first time a high uptake of BSO compared to other minorities. I also conducted the first known clinical trial that prospectively tested the hypothesis that HER2 targeted therapies may be safely administered in patients with mildly reduced cardiac function, and the results of this trial are commonly used to guide clinical decisions related to the care of these patients

Working Experience

  • Brigham and Women’s Hospital (BWH), Boston, MA, Medical Oncology Associate Physician (2021-present)
  • Dana-Farber Cancer Institute, Boston, MA, Associate Director, Inflammatory Breast Cancer Program (2020-present)
  • Dana-Farber Cancer Institute, Boston, MA, Medical Oncology Physician (2020-present)
  • Harvard Medical School, Boston, MA, Assistant Professor (2021)
  • Harvard Medical School, Boston, MA, Member of the Faculty (2020-2021)
  • Georgetown University School of Medicine, Washington, DC, Associate Professor (2018-2020)
  • Atlantic Coast Phase 2 Consortium (ACP2C), Johns Hopkins University, Disease Focused Investigator, Breast/GYN/Phase 1 (2019-2020)
  • Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, Interim Medical Director, Clinical Research Management Office (2019-2020)
  • Fisher Center for Hereditary Cancer and Clinical Genomics Research, Full Member (2015-2020)
  • Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, Medical Oncology Staff Physician (2015-2020)
  • Georgetown University School of Medicine, Washington, DC, Director, Clinical Conference on Breast Cancer Course (2015-2020)
  • Georgetown University School of Medicine, Washington, DC, Assistant Professor (2015-2018)
  • MedStar Washington Hospital Center, Washington, DC, Medical Oncology Staff Physician (2015-2017)
  • MedStar Washington Hospital Center / MedStar Georgetown University Hospital, Hematology/Oncology Chief Fellow (2013-2014)
  • MedStar Washington Hospital Center / MedStar Georgetown University Hospital, Hematology/Oncology Fellow (2011-2013)
  • MedStar Washington Hospital Center / MedStar Georgetown University Hospital, Washington, DC, Internal Medicine Intern/Resident (2008-2011)
  • Portuguese Institute of Oncology, Lisbon, Portugal, Medical Oncology Resident (2006-2008)
  • Hospital Egas Moniz, Lisbon, Portugal, Pediatrics and General Surgery Intern (2005-2006)

Education and Board Certifications

MD

Faculdade de Ciências Médicas, Universidade Nova Lisboa, Lisbon, Portugal

MD

District of Columbia

MD

Massachusetts

MD

American Board of Internal Medicine

Medical Oncology

American Board of Internal Medicine

Hematology

American Board of Internal Medicine

BS

Colégio São João de Brito, Lisbon, Portugal

Affiliations and Memberships

Georgetown Lombardi Comprehensive Cancer Center Data and Safety Monitoring Committee, 2015

Georgetown University PhD Thesis Committee, 2015-2018

Georgetown Lombardi Comprehensive Cancer Center Breast Tissue Microarray Subcommittee, 2016-2018

Georgetown University KL2 Mentoring Committee, 2017-2020

Georgetown Women in Medicine Board, Member-at-Large, 2018-2020

Georgetown University Medical Center Program Education Committee Hematology/Oncology Fellowship Program Chair, 2019-2020

Dana-Farber Cancer Institute Breast Oncology Center for BRCA and Related Genes Team Liaison, 2020-present

Dana-Farber Cancer Institute IBC Multidisciplinary Conference Chair, 2020-present

National Institutes of Health Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis Multi-Institutional Research Consortium Member, 2015-present

Translational Breast Cancer Research Consortium Triple Negative Breast Cancer Working Group Member, 2015-present

ALLIANCE for Clinical Trials in Oncology Institutional Principal Investigator (Georgetown LCCC representative), 2018-2020

ALLIANCE for Clinical Trials in Oncology Board of Directors (Georgetown LCCC representative), 2018-2020

UT Health Cancer Center/Institute for Health Promotion Research, San Antonio, TX Scientific Planning Committee Advancing the Science of Cancer in Latinos Member, 2018-present

Hoosier Cancer Research Network, Indianapolis, IN Breast Committee Co-Chair, 2019-2020

American Society of Clinical Oncology, 2011-present

American Society of Clinical Oncology Fellow’s Council, 2012-2015

American Society of Clinical Oncology Member, Professional Development Committee, 2012-2015

American Society of Clinical Oncology Member, Workforce Advisory Group, 2015-2019

American Society of Clinical Oncology Liaison, Health Disparities Committee, 2017-2019

American Society of Clinical Oncology Member, Grant Selection Committee, Diversity in Oncology Initiative Subcommittee, 2017-present

American Society of Clinical Oncology Member, Test Materials Development Committee Working Group, 2018-2021

Affiliated IBC-IC Center(s)

  • Dana-Farber Cancer Institute Inflammatory Breast Cancer Program
  • Boston, MA, 02215
  • Research + Treatment Center

Join IBC-IC

Become part of our international consortium of researchers, clinicians, advocates and centers worldwide dedicated to ending IBC.

IBCIC.org makes every effort to keep researcher information as up-to-date as possible.
Contact this researcher to confirm any information regarding his or her profile.